Tag: CBT > DEA Cannabis Policy and Legalization: Page 2

Kentucky

Kentucky Governor Urges DEA to Reschedule: ‘The Jury is No Longer Out on Marijuana’

Gov. Andy Beshear wrote a letter to DEA Administrator Anne Milgram expressing his support for reclassifying cannabis to a Schedule III substance.

July 17, 2024

Cannabis Rescheduling

US Congressmen Press DEA Head to Explain Her Signature Absence on Cannabis Rescheduling Document

The agency’s administrator, Anne Milgram, did not personally approve the notice of proposed rulemaking to reclassify cannabis on May 16.

May 23, 2024

Banking Services Cannabis Industry

Federal Marijuana Rescheduling on the Horizon: A Big Step Forward But Not the Be-All-End-All

Rescheduling does not make cannabis legal throughout America and the U.S. territories; It makes cannabis a federally regulated medication—and many questions remain about the fate of the industry.

May 23, 2024

Oklahoma

DEA 2024 Report Focuses on THC Potency, Organized Crime, Youth Edible Consumption

The federal agency’s National Drug Threat Assessment calls attention to how scheduled substances and trafficking trends are “endangering” the U.S.

May 17, 2024

Cannabis Rescheduling

White House Moves to Reschedule Cannabis in ‘Monumental’ Decision, Biden Says

The Department of Justice will issue a notice of proposed rulemaking to reclassify cannabis in the Federal Register, which will be followed by a 60-day public comment period prior to the department potentially finalizing the rule.

May 16, 2024

Cannabis Industry Research

Cannabis Company Sues DEA Over Application to Grow for Clinical Trials

Rhode Island-based MMJ BioPharma Cultivation Inc. is seeking an order to halt the DEA’s ‘unconstitutional actions’ as it awaits approval to grow cannabis.

April 8, 2024

Florida

The Future of Hemp-Derived Delta-9 THC Headlines CBT’s Most-Read Articles for March

Readers also dove headfirst into Amazon’s delta-8 problems and a potential rescheduling roadblock with the DEA’s five-factor test this month.

March 28, 2024

Cannabis Rescheduling

3 GOP Senators Tell DEA Not to Reschedule Cannabis

Led by former presidential candidate Mitt Romney, the senators argue rescheduling would violate an international treaty in letter to DEA administrator.

March 27, 2024

Cannabis Rescheduling

DEA’s 5-Factor Test Makes Rescheduling Cannabis Impossible

After HHS used its own two-part test to determine the plant’s ‘currently accepted medical use,’ rescheduling opponents urge DEA to keep its five-part test.

March 19, 2024

New Mexico

Bright Green Corp. Submits DEA Registration For Production of Schedule I, II Controlled Substances

The application follows the company’s approval from the New Mexico Board of Pharmacy this year.

March 7, 2024

North Carolina

2 US Senators Urge DEA, Other Agencies to ‘Uphold’ Law on Tribal Cannabis Sales in North Carolina

The Eastern Band of Cherokee Indians plans to launch the state’s first adult-use cannabis sales on April 20.

March 5, 2024

South Carolina

Jamaica’s THC Exports to United States Leads CBT’s Most Popular Articles in February

Rescheduling, state legalization prospects, and Lume’s rapid rise in Michigan also ranked in Cannabis Business Times’ top 10 stories this month.

February 29, 2024